The Oncology Care Model: Roadmap or Distraction for Commercial Payers?
It's clear that Medicare needs a proactive cancer strategy, hence the launch of the Oncology Care Model.
Ranking Value in Cancer Care: Analysis of a "Pathways" Approach
Amid a continuing debate over healthcare spending in the United States, the oncology community is growing more introspective about the costs associated with increasingly sophisticated cancer therapeutics.
Dr Phillips on the Treatment Landscape for Patients With MCL
Dr Chari on the Bridging the Gaps in Hematologic Malignancies Meeting
Dr Danilov on Addressing Unmet Needs in Hematologic Malignancies
Dr Saeed on the Use of Pola-R-CHP in Previously Untreated DLBCL
2 Commerce Drive Cranbury, NJ 08512